Custom Search
|
|||||||||||||||||||||
RSD Alert
|
|||||||||||||||||||||
| If you came direct to this page from a search engine and you don't know about this chronic pain condition (now called CRPS, but traditionally known as RSD), please take time to visit our Home page and learn about this painful condition. |
RSD Alert is a voluntary organisation
publishing information about CRPS (traditionally knwn as RSD). Most
of the data is provided by our readers.
All approved medical drugs work for some people but not for everyone.
Don't be alarmed by what you read. Many of our pages show both good
and bad comments... read both to get a balanced view. If in doubt
consult your medical advisor.
To contact one of the RSD Alert Team click CONTACT.
To pass on information for publication
in "Drugs on RSD Alert" click Submit Info.
NOTE: we do not reply to submissions. If you have questions
needing a reply click the CONTACT button (above).
 |
stories - treatments - drug reviews - FAQ - storyboard - tips - help groups - privacy policy
|
Drugs |
Drugs on RSD Alert
(notes and comments from correspondents) |
Pamidronate |
|
Description |
Pamidronate belongs to a pharmacological family called bisphosphonates. The bisphosphonates have been used for treatment of post menopausal osteoporosis and Paget disease. The main action of these drugs is to decrease the rate of bone destruction, leading to an increase of the bone density. |
Side effects(Don't be unduly alarmed. All drugs cause side effects for some patients) |
Fever, diarrhoea. |
Warnings(These are standard cautions but may not apply in your case) |
{warnings} |
Comments |
|
| A French study evaluated the efficacy of treatment with pamidronate in 29 patients with RSD(60 mg/day for 3 days). By day 45, 86.2% of patients reported that pain had disappeared and 70% showed signs of functional improvement. On average, their pain disappeared in about 2 weeks and functional improvement was observed in about 3 weeks. Improvement seemed to come sooner in patients with post-traumatic RSD. Further studies are planned, including full 'double blind' placebo trials. Information provided by Barry Swallow of RSD-CRPS UK | |
|
www.rsdalert.co.uk
for correspondence click CONTACT |
|